These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 17545595)
1. Inhibition of tumor growth and metastasis by depletion of vesicular sorting protein Hrs: its regulatory role on E-cadherin and beta-catenin. Toyoshima M; Tanaka N; Aoki J; Tanaka Y; Murata K; Kyuuma M; Kobayashi H; Ishii N; Yaegashi N; Sugamura K Cancer Res; 2007 Jun; 67(11):5162-71. PubMed ID: 17545595 [TBL] [Abstract][Full Text] [Related]
2. TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. Lu Q; Hope LW; Brasch M; Reinhard C; Cohen SN Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7626-31. PubMed ID: 12802020 [TBL] [Abstract][Full Text] [Related]
3. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981. Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724 [TBL] [Abstract][Full Text] [Related]
4. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription. Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436 [TBL] [Abstract][Full Text] [Related]
5. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer. Mareel M; Vleminckx K; Vermeulen S; Yan G; Bracke M; van Roy F Princess Takamatsu Symp; 1994; 24():63-80. PubMed ID: 8983064 [TBL] [Abstract][Full Text] [Related]
6. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism. Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP Cancer Res; 2007 Aug; 67(16):7654-64. PubMed ID: 17699770 [TBL] [Abstract][Full Text] [Related]
7. Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells. Shibata T; Ochiai A; Kanai Y; Akimoto S; Gotoh M; Yasui N; Machinami R; Hirohashi S Oncogene; 1996 Sep; 13(5):883-9. PubMed ID: 8806677 [TBL] [Abstract][Full Text] [Related]
8. Hrs regulates the endocytic sorting of the fibroblast growth factor receptor 2b. Belleudi F; Leone L; Maggio M; Torrisi MR Exp Cell Res; 2009 Aug; 315(13):2181-91. PubMed ID: 19362549 [TBL] [Abstract][Full Text] [Related]
9. E-cadherin regulates the association between beta-catenin and actinin-4. Hayashida Y; Honda K; Idogawa M; Ino Y; Ono M; Tsuchida A; Aoki T; Hirohashi S; Yamada T Cancer Res; 2005 Oct; 65(19):8836-45. PubMed ID: 16204054 [TBL] [Abstract][Full Text] [Related]
10. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. Wilding J; Vousden KH; Soutter WP; McCrea PD; Del Buono R; Pignatelli M Cancer Res; 1996 Nov; 56(22):5285-92. PubMed ID: 8912870 [TBL] [Abstract][Full Text] [Related]
12. Protein kinase D1-mediated phosphorylation and subcellular localization of beta-catenin. Du C; Jaggi M; Zhang C; Balaji KC Cancer Res; 2009 Feb; 69(3):1117-24. PubMed ID: 19141652 [TBL] [Abstract][Full Text] [Related]
13. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184 [TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-independent binding of Hrs mediates endosomal sorting of the interleukin-2 receptor beta-chain. Yamashita Y; Kojima K; Tsukahara T; Agawa H; Yamada K; Amano Y; Kurotori N; Tanaka N; Sugamura K; Takeshita T J Cell Sci; 2008 May; 121(Pt 10):1727-38. PubMed ID: 18445679 [TBL] [Abstract][Full Text] [Related]
15. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. Yuan Z; Wong S; Borrelli A; Chung MA Biochem Biophys Res Commun; 2007 Oct; 362(3):740-6. PubMed ID: 17764657 [TBL] [Abstract][Full Text] [Related]
17. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor. DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959 [TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Kajiyama H; Kikkawa F; Khin E; Shibata K; Ino K; Mizutani S Cancer Res; 2003 May; 63(9):2278-83. PubMed ID: 12727850 [TBL] [Abstract][Full Text] [Related]
19. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296 [TBL] [Abstract][Full Text] [Related]
20. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction. Lin CY; Lin CJ; Chen KH; Wu JC; Huang SH; Wang SM FEBS Lett; 2006 May; 580(13):3042-50. PubMed ID: 16678166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]